We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood Pathogens Rapidly Identified by Novel Molecular Methods

By LabMedica International staff writers
Posted on 12 Nov 2013
Rapid and accurate identification of pathogens responsible for sepsis, a life-threatening medical condition that is defined as systemic inflammatory response syndrome, is essential for early and targeted antimicrobial therapy.

Blood cultures represent the reference standard for the detection and identification of pathogens that cause bloodstream infections but conventional culture-based identification systems are time consuming but can be improved by using additional test systems.

Microbiologists at the Medical University of Graz (Austria) examined 103 positive blood cultures collected from December 2012 until March 2013. More...
Blood cultures were obtained from patients with suspected sepsis as part of the standard hospital care and transferred to the laboratories.

The investigators evaluated the hemoFISH test using Beacon-Based Fluorescence in Situ Hybridization (bbFISH) technology for accurate identification of microorganisms in positive blood cultures by comparison with culture-based identification methods. The hemoFISH assay (miacom diagnostics, Inc.; Düsseldorf, Germany) is an in vitro diagnostic/Conformité Européene (CE) labeled test system that uses the bbFISH technology.

A total number of 103 positive blood culture bottles, with 59.0% grown in BACTEC Plus Aerobic/F and 41.0% BACTEC Plus Anaerobic/F (Becton Dickinson Diagnostic Systems; Franklin Lakes, NJ, USA), were tested. Culture-dependent identification with the use of the reference methods of mass spectrometry (MALDI-TOF MS Shimatzu Corporation; Kyoto, Japan) or Vitek2 (bioMérieux; Marcyl`Etoile, France) indicated that 95.1% of the blood culture bottles showed monomicrobial growth and 4.9% showed polymicrobial growth.

From the 106 bacterial species identified with the reference methods, the hemoFISH correctly identified 55.7% to species level, 34.0% to genus level, 7.5% to family level, and 2.8% were unidentifiable. The hemoFISH assay showed a sensitivity and specificity of 100%. From the 106 slides tested, in 11 cases the readout was initially challenging because of slight autofluorescence from certain probes. These slides were reevaluated and double-checked by a second investigator. In all cases, the result obtained by the two investigators was in agreement with the culture results. The specific fluorescence was much brighter than the observed autofluorescence.

The authors concluded that the hemoFISH assay that uses the novel bbFISH technology is an easy-to-handle, rapid, reliable tool for the identification of a broad range of microorganisms and facilitates the decision of antimicrobial therapy in septic patients. The study was published in the November 2013 issue of the Journal of Molecular Diagnostics.

Related Links:

Medical University of Graz
miacom diagnostics
Becton Dickinson Diagnostic Systems 



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
New
PlGF Test
Quidel Triage PlGF Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.